SFMG Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,845
Closed -$4.41M 353
2026
Q1
$4.41M Sell
50,845
-2,228
-4% -$213K 0.3% 47
2025
Q4
$5.1M Buy
53,073
+2,259
+4% +$219K 0.34% 45
2025
Q3
$4.84M Buy
50,814
+1,350
+3% +$124K 0.34% 44
2025
Q2
$4.31M Buy
49,464
+927
+2% +$78.6K 0.32% 43
2025
Q1
$4.36M Buy
48,537
+1,792
+4% +$160K 0.34% 41
2024
Q4
$3.73M Sell
46,745
-374
-0.8% -$32.4K 0.29% 46
2024
Q3
$4.24M Sell
47,119
-496
-1% -$41.7K 0.34% 38
2024
Q2
$3.75M Buy
47,615
+1,708
+4% +$140K 0.33% 42
2024
Q1
$4M Buy
45,907
+1,465
+3% +$125K 0.34% 43
2023
Q4
$3.66M Buy
44,442
+2,382
+6% +$182K 0.34% 41
2023
Q3
$3.3M Buy
42,060
+2,852
+7% +$239K 0.34% 40
2023
Q2
$3.45M Buy
39,208
+3,152
+9% +$271K 0.36% 38
2023
Q1
$2.91M Buy
36,056
+2,952
+9% +$241K 0.31% 46
2022
Q4
$2.57M Buy
+33,104
New +$2.68M 0.29% 51

Other funds holding MDT

SFMG Wealth Advisors's MDT Position: Q2 2026 in Review

SFMG Wealth Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 50,845 shares — an estimated $4.41M sold.

SFMG Wealth Advisors first reported a position in MDT in Q4 2022 and held it in 14 quarters. The position peaked at $5.1M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • SFMG Wealth Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • SFMG Wealth Advisors sold 50,845 Medtronic shares in Q2 2026, an estimated $4.41M.
  • SFMG Wealth Advisors first reported a position in Medtronic in Q4 2022 and held it in 14 quarters.
  • SFMG Wealth Advisors's Medtronic position peaked at $5.1M in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.